These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 12164297)
1. The detection of Mycobacterium leprae protein and carbohydrate antigens in skin and nerve from leprosy patients with type 1 (reversal) reactions. Lockwood DN; Colston MJ; Khanolkar-Young SR Am J Trop Med Hyg; 2002 Apr; 66(4):409-15. PubMed ID: 12164297 [TBL] [Abstract][Full Text] [Related]
2. Immunohistological analysis of in situ expression of mycobacterial antigens in skin lesions of leprosy patients across the histopathological spectrum. Association of Mycobacterial lipoarabinomannan (LAM) and Mycobacterium leprae phenolic glycolipid-I (PGL-I) with leprosy reactions. Verhagen C; Faber W; Klatser P; Buffing A; Naafs B; Das P Am J Pathol; 1999 Jun; 154(6):1793-804. PubMed ID: 10362804 [TBL] [Abstract][Full Text] [Related]
3. In situ demonstration of Mycobacterium leprae antigens in leprosy lesions using monoclonal antibodies. Narayanan RB; Girdhar BK; Malaviya GN; Sengupta U Immunol Lett; 1990 Jun; 24(3):179-83. PubMed ID: 2200752 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of PGL-1, LAM, 30 kD and 65 kD antigens in leprosy infected paraffin preserved skin and nerve sections. Van den Bos IC; Khanolkar-Young S; Das PK; Lockwood DN Lepr Rev; 1999 Sep; 70(3):272-80. PubMed ID: 10603716 [TBL] [Abstract][Full Text] [Related]
5. Demonstration of mycobacterial antigens in nerve biopsies from leprosy patients using peroxidase-antiperoxidase immunoenzyme technique. Mshana RN; Humber DP; Harboe M; Belehu A Clin Immunol Immunopathol; 1983 Dec; 29(3):359-68. PubMed ID: 6416726 [TBL] [Abstract][Full Text] [Related]
6. Immunohistological localization of mycobacterial antigens within the peripheral nerves of treated leprosy patients and their significance to nerve damage in leprosy. Shetty VP; Uplekar MW; Antia NH Acta Neuropathol; 1994; 88(4):300-6. PubMed ID: 7839822 [TBL] [Abstract][Full Text] [Related]
7. Demonstration of Mycobacterium leprae antigen in nerves of tuberculoid leprosy. Barros U; Shetty VP; Antia NH Acta Neuropathol; 1987; 73(4):387-92. PubMed ID: 2441563 [TBL] [Abstract][Full Text] [Related]
9. Anti-Mycobacterium leprae monoclonal antibodies cross-react with human skin: an alternative explanation for the immune responses in leprosy. Naafs B; Kolk AH; Chin A Lien RA; Faber WR; Van Dijk G; Kuijper S; Stolz E; Van Joost T J Invest Dermatol; 1990 May; 94(5):685-8. PubMed ID: 1691241 [TBL] [Abstract][Full Text] [Related]
10. Events surrounding the recognition of Mycobacterium leprae in nerves. Ridley MJ; Waters MF; Ridley DS Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):99-108. PubMed ID: 3549942 [TBL] [Abstract][Full Text] [Related]
11. Tumour necrosis factor-alpha (TNF-alpha) synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions. Khanolkar-Young S; Rayment N; Brickell PM; Katz DR; Vinayakumar S; Colston MJ; Lockwood DN Clin Exp Immunol; 1995 Feb; 99(2):196-202. PubMed ID: 7851011 [TBL] [Abstract][Full Text] [Related]
12. The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients. Roche PW; Britton WJ; Neupane KD; Failbus SS; Cho SN; Theuvenet WJ Am J Trop Med Hyg; 1991 Jun; 44(6):702-8. PubMed ID: 1858971 [TBL] [Abstract][Full Text] [Related]
13. Demonstration of Mycobacterium leprae specific antigens in leprosy lesions using monoclonal antibodies. Narayanan RB; Ramu G; Sinha S; Sengupta U; Malaviya GN; Desikan KV Indian J Lepr; 1985; 57(2):258-64. PubMed ID: 2416852 [TBL] [Abstract][Full Text] [Related]
14. Reactions in leprosy. Bjune G Lepr Rev; 1983 Jun; Spec No():61-7. PubMed ID: 6224993 [No Abstract] [Full Text] [Related]
15. Novel mechanisms in the immunopathogenesis of leprosy nerve damage: the role of Schwann cells, T cells and Mycobacterium leprae. Spierings E; De Boer T; Zulianello L; Ottenhoff TH Immunol Cell Biol; 2000 Aug; 78(4):349-55. PubMed ID: 10947859 [TBL] [Abstract][Full Text] [Related]
16. Persistence of Mycobacterium leprae in the peripheral nerve as compared to the skin of multidrug-treated leprosy patients. Shetty VP; Suchitra K; Uplekar MW; Antia NH Lepr Rev; 1992 Dec; 63(4):329-36. PubMed ID: 1479872 [TBL] [Abstract][Full Text] [Related]
17. In leprosy the presence of mycobacteria in the nerve is an essential factor in the cycle and spectrum of Mycobacterium leprae infection. Negesse Y; Beimnet K; Miko T; Wondimus A; Berhan TY Lepr Rev; 1993 Jun; 64(2):104-9. PubMed ID: 8341112 [TBL] [Abstract][Full Text] [Related]
18. Identification of Mycobacterium leprae antigens in tissues of leprosy patients using monoclonal antibodies. Khanolkar SR; Mackenzie CD; Lucas SB; Hussen A; Girdhar BK; Katoch K; McAdam KP Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):652-8. PubMed ID: 2674303 [TBL] [Abstract][Full Text] [Related]
19. Mycobacterium leprae-specific, HLA class II-restricted killing of human Schwann cells by CD4+ Th1 cells: a novel immunopathogenic mechanism of nerve damage in leprosy. Spierings E; de Boer T; Wieles B; Adams LB; Marani E; Ottenhoff TH J Immunol; 2001 May; 166(10):5883-8. PubMed ID: 11342602 [TBL] [Abstract][Full Text] [Related]
20. [The identification of the antigenic determinants of Mycobacterium leprae passed through laboratory animals by using monoclonal antibodies]. Diachin MN; Iushchenko AA; Ibragimov ChD; Chernousova LN; Litvinov VI Zh Mikrobiol Epidemiol Immunobiol; 1994; (1):73-6. PubMed ID: 7514328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]